Study Stopped
Difficulties in including Mild Traumatic Brain Injury (mTBI) group despite an extended inclusion period of an additional 12 months
Multimodal Neuroimaging Analysis After Mild Traumatic Brain Injury
CHANGE-TBI
Cerebral Microstructural and Functional Changes After Single and Repeated Mild Traumatic Brain Injury
1 other identifier
interventional
41
1 country
1
Brief Summary
Mild Traumatic Brain Injury (mTBI), including concussion, is a real public health problem. Indeed mTBI might induce long-term brain disorders with increased risk of neurodegenerative diseases and the healthcare costs can be significant for both the individual and the society. However mTBI is called the "silent epidemic", because of the lack of research in this field in France as well as in the rest of the world. Most of the time, mTBI is associated with sports injuries, road traffic accidents and falls. The risk of neurodegenerative diseases is significantly increased with the repetition of mTBI, which may have a cumulative effect. In this context, playing football (or 'soccer') is associated with a high risk of concussion and with frequent head-ball contacts which are repeated during the training and matches. Moreover, football is the most popular team sport in the world, with more than 265 million players. The long-term impact of "heading" in football is still debated in the literature. Nevertheless, several studies suggest the possible emergence of early neurocognitive disorders. Otherwise, while mTBI is usually characterized by normal brain images using traditional neuroimaging techniques, microscopic anatomical changes might be detectable by new neuroimaging techniques. According to recent studies, cognitive dysfunctions could be based on these microstructural changes in the gray matter and white matter, secondary to the primary mechanical injury. Studies that have examined the structural changes in the brain white matter in football players are rare and lack of evidence regarding the consequences of accumulated brain impacts explains the lack of preventive measures in this sport. In addition, post-traumatic secondary lesions cause functional alterations of the neurovascular unit and its effect on cerebral perfusion may play a crucial role, which has never been yet explored in humans over the long term. In this research, the investigators will develop a unique multi-modal neuroimaging protocols to assess brain changes after minor head trauma and over the time. Investigators want to perform magnetic resonance imaging (MRI) to assess cerebral blood flow using Arteria Spin Labelling (ASL), structural changes using Diffusion Tensor Imaging (DTI), susceptibility weighted imaging (SWI), and functional changes using BOLD resting-functional MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2016
CompletedFirst Submitted
Initial submission to the registry
August 3, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2018
CompletedFebruary 26, 2019
February 1, 2019
1.5 years
August 3, 2017
February 22, 2019
Conditions
Outcome Measures
Primary Outcomes (8)
Fractional anisotropy (FA) measure
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Month 0
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Fractional anisotropy (FA) measure by Magnetic Resonance Imaging
Month 12
Radial diffusivity (RD) measure
Radial diffusivity (RD) measure by Magnetic Resonance Imaging
Month 0
Radial diffusivity (RD) measure
Radial diffusivity (RD) measure by Magnetic Resonance Imaging
Month 12
Mean diffusivity (MD) measure
Mean diffusivity (MD) measure by Magnetic Resonance Imaging
Month 0
Mean diffusivity (MD) measure
Mean diffusivity (MD) measure by Magnetic Resonance Imaging
Month 12
Axial diffusivity (AD) measure
Axial diffusivity (AD) measure by Magnetic Resonance Imaging
Month 0
Axial diffusivity (AD) measure
Axial diffusivity (AD) measure by Magnetic Resonance Imaging
Month 12
Secondary Outcomes (14)
Brain areas on MRI sequences
Month 0
Brain areas on MRI sequences
Month 12
Brain's white matter injury volume on MRI
Month 0
Brain's white matter injury volume on MRI
Month 12
Micro-bleedings measure
Month 0
- +9 more secondary outcomes
Study Arms (1)
Brain Magnetic Resonance Imaging (MRI)
EXPERIMENTALNeuroimaging protocol to assess brain changes after minor head trauma and over the time.
Interventions
Eligibility Criteria
You may qualify if:
- Applicable to all :
- \- Male 18 to 25 years, enrolled in French Social Security.
- Group of mTBI patients:
- \- Diagnosis of mTBI in the last 2 weeks confirmed in emergency department of Bordeaux CHU, using the WHO definition (2004): "head trauma ≤ 24h with Glasgow Coma Scale score of 13-15 and with one or more of the three symptoms following: confusion or disorientation, loss of consciousness for 30 minutes or less, posttraumatic amnesia for less than 24h".
- Group of footballers:
- \- Member of the "CFA" and "U19" teams of "Girondins de Bordeaux".
- Group of controls:
- \- Practicing regular physical activity (excluding combat or contact sports).
You may not qualify if:
- Abnormal neurological examination
- Drug addiction including alcohol Taking drugs targeting the central nervous system History of head trauma, or other notion of central nervous system injury
- History of severe high blood pressure, diabetes, chronic cardiovascular pathology, progressive or debilitating disease
- Subject unable to give informed consent
- Contraindication to MRI: head circumference\> 60 - Claustrophobia - Pacemaker, Implantable Neurostimulation, Implantable Defibrillator - Cochlear Implants - Ocular or cerebral ferromagnetic foreign body
- Refusal to be informed of an abnormality detected during MRI.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Bordeaux
Bordeaux, 33076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2017
First Posted
November 17, 2017
Study Start
July 18, 2016
Primary Completion
January 29, 2018
Study Completion
January 29, 2018
Last Updated
February 26, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share